Intragraft Th17 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection

Journal of Immunology

Volumn 184, Issue 9, 2010, Pages 5344-5351

  Deteix, Clémence ^a,b   Attuil Audenis, Valérie ^a,b   Duthey, Aurélie ^a,b   Patey, Natacha ^d   McGregor, Brigitte ^b   Dubois, Valérie ^b,c   Caligiuri, Giuseppina ^d,e   Graff Dubois, Stéphanie ^d,e   Morelon, Emmanuel ^a,b   Thaunat, Olivier ^a,b  

^a UNIVERSITÉ LYON 1   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; CYTIDINE DEAMINASE; EVEROLIMUS; INTERLEUKIN 17; INTERLEUKIN 21; MYCOPHENOLIC ACID; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; AUTACOID;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURVIVAL; CELLULAR DISTRIBUTION; CHILD; CHRONIC GRAFT REJECTION; CLINICAL ARTICLE; ECTOPIC TISSUE; ENZYME ACTIVATION; FEMALE; GERMINAL CENTER; GLUCONEOGENESIS; GRAFT SURVIVAL; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; LYMPHOID CELL; MALE; POLARIZATION; PRESCHOOL CHILD; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH17 CELL; ADOLESCENT; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL MOTION; CHRONIC DISEASE; DISEASE COURSE; GRAFT REJECTION; IMMUNOLOGY; LYMPHOID TISSUE; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY;

ADOLESCENT; ADULT; AGED; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL MOVEMENT; CHILD, PRESCHOOL; CHRONIC DISEASE; DISEASE PROGRESSION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-17; KIDNEY TRANSPLANTATION; LYMPHOID TISSUE; MALE; MIDDLE AGED;

EID: 77954467012     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902999     Document Type: Article

References (44)

1. Sayegh, M. H., and C. B. Carpenter. 2004. Transplantation 50 years later - progress, challenges, and promises. N. Engl. J. Med. 351: 2761-2766.
2. Bohman, S. O., H. E. Wilczek, F. P. Reinholt, E. von Willebrand, and P. Häyry. 1991. Immunopathological patterns in long-term renal allografts. Transplantation 51: 610-613.
3. Shimizu, A., K. Yamada, D. H. Sachs, and R. B. Colvin. 2000. Intragraft events preceding chronic renal allograft rejection in a modified tolerance protocol. Kidney Int. 58: 2546-2558.
4. Zhou, L., M. M. Chong, and D. R. Littman. 2009. Plasticity of CD4+ T cell lineage differentiation. Immunity 30: 646-655.
5. Le Moine, A., and M. Goldman. 2003. Non-classical pathways of cell-mediated allograft rejection: new challenges for tolerance induction? Am. J. Transplant. 3: 101-106. (Pubitemid 36323107)
6. Le Moine, A., M. Goldman, and D. Abramowicz. 2002. Multiple pathways to allograft rejection. Transplantation 73: 1373-1381.
7. Chen, Y., and K. J. Wood. 2007. Interleukin-23 and TH17 cells in transplantation immunity: does 23+17 equal rejection? Transplantation 84: 1071-1074.
8. Yuan, X., J. Paez-Cortez, I. Schmitt-Knosalla, F. D'Addio, B. Mfarrej, M. Donnarumma, A. Habicht, M. R. Clarkson, J. Iacomini, L. H. Glimcher, et al. 2008. A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy. J. Exp. Med. 205: 3133-3144.
9. Wood, K. J., and S. Sakaguchi. 2003. Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 3: 199-210.
10. Zelenika, D., E. Adams, S. Humm, C. Y. Lin, H. Waldmann, and S. P. Cobbold. 2001. The role of CD4+ T-cell subsets in determining transplantation rejection or tolerance. Immunol. Rev. 182: 164-179.
11. Zuber, J., A. Brodin-Sartorius, N. Lapidus, N. Patey, M. Tosolini, S. Candon, M. Rabant, R. Snanoudj, C. Panterne, E. Thervet, et al. 2009. FOXP3-enriched infiltrates associated with better outcome in renal allografts with inflamed fibrosis. Nephrol. Dial. Transplant. 24: 3847-3854.
12. Meier-Kriesche, H. U., J. D. Schold, and B. Kaplan. 2004. Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am. J. Transplant. 4: 1289-1295.
13. Solez, K., R. B. Colvin, L. C. Racusen, M. Haas, B. Sis, M. Mengel, P. F. Halloran, W. Baldwin, G. Banfi, A. B. Collins, et al. 2008. Banff 07 classification of renal allograft pathology: updates and future directions. Am. J. Transplant. 8: 753-760.
14. Jeong, H. J., S. W. Hong, Y. S. Kim, M. S. Kim, I. H. Choi, K. Park, and I. J. Choi. 1996. Interstitial mononuclear cell infiltrates in chronic rejection of the kidney and correlation with peripheral blood. J. Korean Med. Sci. 11: 489-494.
15. Ouyang, W., S. H. Ranganath, K. Weindel, D. Bhattacharya, T. L. Murphy, W. C. Sha, and K. M. Murphy. 1998. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 9: 745-755. (Pubitemid 28557602)
16. Korn, T., E. Bettelli, M. Oukka, and V. K. Kuchroo. 2009. IL-17 and Th17 Cells. Annu. Rev. Immunol. 27: 485-517.
17. Kerjaschki, D., H. M. Regele, I. Moosberger, K. Nagy-Bojarski, B. Watschinger, A. Soleiman, P. Birner, S. Krieger, A. Hovorka, G. Silberhumer, et al. 2004. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J. Am. Soc. Nephrol. 15: 603-612.
18. Thaunat, O., A. C. Field, J. Dai, L. Louedec, N. Patey, M. F. Bloch, C. Mandet, M. F. Belair, P. Bruneval, O. Meilhac, et al. 2005. Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response. Proc. Natl. Acad. Sci. USA 102: 14723-14728.
19. Durandy, A. 2003. Activation-induced cytidine deaminase: a dual role in class-switch recombination and somatic hypermutation. Eur. J. Immunol. 33: 2069-2073.
20. Yu, D., S. Rao, L. M. Tsai, S. K. Lee, Y. He, E. L. Sutcliffe, M. Srivastava, M. Linterman, L. Zheng, N. Simpson, et al. 2009. The Transcriptional Repressor Bcl-6 Directs T Follicular Helper Cell Lineage Commitment. Immunity 31: 457-468.
21. Thaunat, O., and A. Nicoletti. 2008. Lymphoid neogenesis in chronic rejection. Curr. Opin. Organ Transplant. 13: 16-19.
22. Thaunat, O., N. Patey, C. Gautreau, S. Lechaton, V. Fremeaux-Bacchi, M. C. Dieu-Nosjean, E. Cassuto-Viguier, C. Legendre, M. Delahousse, P. Lang, et al. 2008. B cell survival in intragraft tertiary lymphoid organs after rituximab therapy. Transplantation 85: 1648-1653.
23. Thaunat, O., N. Patey, E. Morelon, J. B. Michel, and A. Nicoletti. 2006. Lymphoid neogenesis in chronic rejection: the murderer is in the house. Curr. Opin. Immunol. 18: 576-579.
24. Böhmig, G. A., M. Exner, A. Habicht, M. Schillinger, U. Lang, J. Kletzmayr, M. D. Säemann, W. H. Hörl, B. Watschinger, and H. Regele. 2002. Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury. J. Am. Soc. Nephrol. 13: 1091-1099.
25. Colvin, R. B. 2007. Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J. Am. Soc. Nephrol. 18: 1046-1056.
26. Cornell, L. D., R. N. Smith, and R. B. Colvin. 2008. Kidney transplantation: mechanisms of rejection and acceptance. Annu. Rev. Pathol. 3: 189-220.
27. Thaunat, O., C. Legendre, E. Morelon, H. Kreis, and M. F. Mamzer-Bruneel. 2007. To biopsy or not to biopsy? Should we screen the histology of stable renal grafts? Transplantation 84: 671-676.
28. Miossec, P., T. Korn, and V. K. Kuchroo. 2009. Interleukin-17 and type 17 helper T cells. N. Engl. J. Med. 361: 888-898.
29. Tesmer, L. A., S. K. Lundy, S. Sarkar, and D. A. Fox. 2008. Th17 cells in human disease. Immunol. Rev. 223: 87-113.
30. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
31. Kolls, J. K., and A. Lindén. 2004. Interleukin-17 family members and inflammation. Immunity 21: 467-476.
32. Surquin, M., A. Le Moine, V. Flamand, K. Rombaut, F. X. Demoor, I. Salmon, M. Goldman, and D. Abramowicz. 2005. IL-4 deficiency prevents eosinophilic rejection and uncovers a role for neutrophils in the rejection of MHC class II disparate skin grafts. Transplantation 80: 1485-1492. (Pubitemid 41803632)
33. Nurieva, R. I., Y. Chung, D. Hwang, X. O. Yang, H. S. Kang, L. Ma, Y. H. Wang, S. S. Watowich, A. M. Jetten, Q. Tian, and C. Dong. 2008. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 29: 138-149.
34. Vogelzang, A., H. M. McGuire, D. Yu, J. Sprent, C. R. Mackay, and C. King. 2008. A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity 29: 127-137.
35. King, C., S. G. Tangye, and C. R. Mackay. 2008. T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu. Rev. Immunol. 26: 741-766.
36. Ettinger, R., S. Kuchen, and P. E. Lipsky. 2008. The role of IL-21 in regulating B-cell function in health and disease. Immunol. Rev. 223: 60-86.
37. Ozaki, K., R. Spolski, R. Ettinger, H. P. Kim, G. Wang, C. F. Qi, P. Hwu, D. J. Shaffer, S. Akilesh, D. C. Roopenian, et al. 2004. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J. Immunol. 173: 5361-5371. (Pubitemid 39392119)
38. Russell, P. S., C. M. Chase, H. J. Winn, and R. B. Colvin. 1994. Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity. J. Immunol. 152: 5135-5141.
39. Shi, C., W. S. Lee, Q. He, D. Zhang, D. L. Fletcher, Jr., J. B. Newell, and E. Haber. 1996. Immunologic basis of transplant-associated arteriosclerosis. Proc. Natl. Acad. Sci. USA 93: 4051-4056.
40. Terasaki, P. I. 2003. Humoral theory of transplantation. Am. J. Transplant. 3: 665-673.
41. Baddoura, F. K., I. W. Nasr, B. Wrobel, Q. Li, N. H. Ruddle, and F. G. Lakkis. 2005. Lymphoid neogenesis in murine cardiac allografts undergoing chronic rejection. Am. J. Transplant. 5: 510-516.
42. Kratz, A., A. Campos-Neto, M. S. Hanson, and N. H. Ruddle. 1996. Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J. Exp. Med. 183: 1461-1472.
43. Burlingham, W. J., R. B. Love, E. Jankowska-Gan, L. D. Haynes, Q. Xu, J. L. Bobadilla, K. C. Meyer, M. S. Hayney, R. K. Braun, D. S. Greenspan, et al. 2007. IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J. Clin. Invest. 117: 3498-3506.
44. Schaerli, P., K. Willimann, A. B. Lang, M. Lipp, P. Loetscher, and B. Moser. 2000. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J. Exp. Med. 192: 1553-1562.